Home » Centient Biotech Investor
Centient Biotech Investor
The Centient Biotech Investor tm; provides the professional and individual investor with analysis and insights into the dynamic biotech industry. All of our content is written by our Senior Analysts, Frank H. Eeckman, MD, PhD, and Richard Daverman, PhD.
Features include Daily and Weekly News Commentary, Featured Companies, Industry Insights, IPO Watch, Research Highlights and more. Subscription services include email access to our analysts and daily email updates.
Visit his site: BiotechInvestor.com
Centient Biotech Investor's Latest Articles
Page 1 of 5
-
SinoBiomed Wins Approval For External Use Of Growth Factor
on Apr 16, 2007 about SOBM.OB
- Biotech In Review: Dyax Jumps On Positive Data
-
Hedge Fund Increases Heat On PDL BioPharma CEO
on Apr 13, 2007 about PDLI
- Biotech Day In Review: MedImmune Puts Itself Up For Sale
-
Biotech IPO Watch: Simcere Supplies High-End Generics In China
on Apr 12, 2007 about SCR
- Biotech Day In Review: Genentech Beats Estimates Slightly
- Biotech Day In Review: Entereg from GSK and Adolor Fails Test
- Biotech Day In Review: Agilent Buys Stratagene For $245.5 Million
-
J&J Buys Largest Chinese Cosmetics Company For $300 Million
on Apr 09, 2007 about JNJ
- Biotech Week In Review: Positive Territory For 2007
- Biotech In Review: Bidding War Erupts For Biosite
-
Nasdaq To Start China Index
on Apr 05, 2007
- Biotech Day In Review: Roche Buys BioVeris For $600 Million
- Biotech Day In Review: Cell Genesys Climbs On GVAX Results
-
Geron's Stem Cell Patents Revoked
on Apr 04, 2007 about GERN
- China Biotech Review: Cancer Therapeutics Sues Partner Peregrine
- Biotech Day In Review: Roche Picks Up Antibody Firm For $56.5 Million
- Biotech Week In Review: Barron’s Touts Alzheimers Drugs From Wyeth
- Biotech Day In Review: Novartis Pulls Zelnorm Off The Market
- Will Dendreon's Cancer Vaccine Win Final Approval?
- Biotech Day In Review: CuraGen Gets $155 Million For Gene Sequence Division
-
Beijing Med-Pharm Expands Chinese Distribution Network
on Mar 30, 2007 about BJGP
-
Aradigm Revisited: CEO Adds Input to Analysis
on Mar 29, 2007 about ARDM.OB
- Biotech Day In Review: Sanofi-Aventis Lands Cancer Vaccine For $680 Million
- Bypassing Surgery - Will Stents Survive The Bad News?
- Biotech Day in Review: Biosite Takes $85 Offer from Beckman Coulter
- China Biotech Review: Simcere Pharma Files for American IPO
- Biotech Week In Review: Recovering Some Lost Ground
- Biotech in Review: A Perfect Storm for Genentech and Amgen
- Bad News from Amgen and Genentech Takes Toll on Biotech
- Biotech Day in Review: Eisai Buys Morphotek for $325 Million
-
XShares Will Offer Asian Biotech ETF, Range Continues To Expand
on Mar 23, 2007 about FBT
Symbols:
Authors:
July 05, 2008
| Last Updated
16:45
ET
Get Seeking Alpha Free Stock Alerts by Email!
Get Free Stock Alerts by Email!
Most Popular Feeds
-
ETFs
-
US Market
-
Long Ideas
-
Alt. Energy
- Full list of feeds »
Trading Center
Hedge Fund Jobs
Job Seekers:
- Search jobs by category
- Get job alerts by email or live feed
- Apply online
Employers
- See all recruitment options
- Get applications online or by email
- About Seeking Alpha
- About Us
- Contact Us
- What's New
- Readers Feedback
- Contributors
- Contribute an Article
- Feature Your Book
- Our Contributors
- Anonymous Contributions
- Dispute an Article?
- Tools & Widgets
- Stock Market Toolbar
- Stock Search Add-on
- Power Search
- Email Alerts
- Live Feeds (RSS)
- Legal
- Terms of Use
- Privacy
- Copyright
- Advertise
Want to talk to our community?
Got something interesting to say?
- Advertise with Us

Latest Commentson Centient Biotech Investor's Articles